AUTHORS
Carlota Hernández Sanz, Hernán Pinto
ABSTRACT
Purpose To evaluate the efficacy and safety of photothermal bioactivated platelet‐rich plasma for reducing laxity in facial rejuvenation in patients not eligible for other aesthetic treatments due to several comorbidities. Methods A prospective, nonrandomized study was conducted. Efficacy was assessed through a satisfaction scale and the Facial Laxity Rating Scale. Safety assessments were based on the data of all adverse events and the visual analog pain scale. Results Seven patients with a mean age of 51 (standard deviation [SD] 7.46, range 42–63) were included. In six patients (85.7%), the treatment was applied to the face and neck, and in one patient (14.3%), only to the lower half of the face and neck.
